2118 — Advance, North Carolina

2118 is a clinical research site located in Advance, North Carolina, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

2118 has participated in 1 clinical trials.

Therapeutic areas: Advanced Idiopathic Parkinson's Disease.

Sponsors: UCB BIOSCIENCES GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Advance

Browse all research sites in North Carolina · View every site in Advance

• Hillsdale Family Medicine
• Research Site
• Teva Investigational Site 10346
• The MS Center; Advance Neurology and Pain
• Digestive Health Specialists, PA
• Davie Dermatology

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 2118?

2118 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 2118 conducted?

2118 has 1 clinical trials on record. Their work covers Advanced Idiopathic Parkinson's Disease.

Is 2118 accredited by Crixeo Clinical Trials?

2118 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 2118?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.